Methenmadinone acetate (MMA), also known as methylenedehydroacetoxyprogesterone (MDAP) and sold under the brand names Superlutin and Antigest, is a progestin medication which was developed in Czechoslovakia in the 1960s. It is the C17α acetate ester of methenmadinone. MMA given orally shows about 13-fold the progestogenic activity of parenteral progesterone in animal bioassays.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - Methenmadinone acetate (en)
|
rdfs:comment
| - Methenmadinone acetate (MMA), also known as methylenedehydroacetoxyprogesterone (MDAP) and sold under the brand names Superlutin and Antigest, is a progestin medication which was developed in Czechoslovakia in the 1960s. It is the C17α acetate ester of methenmadinone. MMA given orally shows about 13-fold the progestogenic activity of parenteral progesterone in animal bioassays. (en)
|
foaf:depiction
| |
dct:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
sameAs
| |
dbp:wikiPageUsesTemplate
| |
thumbnail
| |
c
| |
CAS number
| |
ChemSpiderID
| |
class
| |
H
| |
IUPAC name
| - [-17-Acetyl-10,13-dimethyl-16-methylidene-3-oxo-1,2,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-17-yl] acetate (en)
|
O
| |
PubChem
| |
routes of administration
| |
SMILES
| |
StdInChI
| |
StdInChIKey
| - UXRDAJMOOGEIAQ-CKOZHMEPSA-N (en)
|
synonyms
| - Superlutin; Superlutine; MMA; Methylene­dehydroacetoxy­progesterone; MDAP; 17α-Hydroxy-16-methylene-δ6-progesterone 17α-acetate; 17α-Acetoxy-16-methylenepregna-4,6-diene-3,20-dione (en)
|
tradename
| - Superlutin, Antigest (en)
|
UNII
| |
width
| |
has abstract
| - Methenmadinone acetate (MMA), also known as methylenedehydroacetoxyprogesterone (MDAP) and sold under the brand names Superlutin and Antigest, is a progestin medication which was developed in Czechoslovakia in the 1960s. It is the C17α acetate ester of methenmadinone. MMA given orally shows about 13-fold the progestogenic activity of parenteral progesterone in animal bioassays. Analogues of methenmadinone acetate include methenmadinone caproate (MMC), which was studied in combination with estradiol valerate as a combined injectable contraceptive (tentative brand name Lutofollin); chlormethenmadinone acetate (chlorsuperlutin; SCH-12600; 6-chloro-MMA), which has been used in combination with mestranol in birth control pills (brand names Biogest, Sterolibrin, Antigest B) and in veterinary medicine (brand name Agelin); bromethenmadinone acetate (bromsuperlutin; 6-bromo-MMA), which was assessed but was never marketed; and melengestrol acetate (methylsuperlutin; 6-methyl-MMA), which is used in veterinary medicine. (en)
|
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
alternative name
| - Superlutin, Antigest (en)
|
CAS number
| |
FDA UNII code
| |
PubChem
| |
class
| |
foaf:isPrimaryTopicOf
| |
is differentFrom
of | |
is Link from a Wikipage to another Wikipage
of | |